Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 33.92M $6.05B Sept. 30, 2015
T. Rowe Price Associates 20.05M $3.58B Sept. 30, 2015
Pershing Square Capital Management 19.47M $3.47B Sept. 30, 2015
ValueAct Holdings 14.99M $2.67B Sept. 30, 2015
FMR 12.86M $2.30B Sept. 30, 2015
JPMORGAN CHASE & CO 8.94M $1.59B Sept. 30, 2015
Paulson & Co 8.89M $1.59B Sept. 30, 2015
Barclays 8.25M $1.47B Sept. 30, 2015
Grantham, Mayo, Van Otterloo & Co 8.18M $1.46B Sept. 30, 2015
CIBC World Markets 7.80M $418.71M March 31, 2012
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
Lone Pine Capital 7.46M $1.33B Sept. 30, 2015
BANK OF MONTREAL /CAN/ 6.43M $1.15B Sept. 30, 2015
Greystone Managed Investment 5.83M $311.84M March 31, 2012
Brahman Capital 5.67M $304.61M March 31, 2012
Brave Warrior Advisors 5.59M $737.27M March 31, 2014
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
GOLDMAN SACHS 5.34M $764.42M Dec. 31, 2014
Toronto-Dominion Bank 5.15M $395.94M Dec. 31, 2015
VIKING GLOBAL INVESTORS 4.99M $890.71M Sept. 30, 2015
Name Goodman & Company, Investment Counsel 4.93M $264.33M March 31, 2012

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Royal Bank of Canada June 30, 2011 6.93M $360.24M
Iridian Asset Management June 30, 2011 5.69M $295.60M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M